| Date | Title | Description |
| 17.03.2023 |
Acutus Medical stock is down despite Street-beating Q4, raised guidance | Acutus Medical (Nasdaq:AFIB) shares took a hit today despite fourth-quarter results that came in ahead of the consensus forecast.
Shares of AFIB fell 11% to 89¢ apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which inc... |
| 09.01.2023 |
Acutus Medical picks new CFO from within, announces 2023 guidance | Takeo Mukai. [Image from Acutus website]Acutus Medical (Nasdaq:AFIB) announced today that it promoted Takeo Mukai to senior vice president and chief financial officer (CFO).
Mukai joined Acutus in July 2021 as VP, finance. He expanded his r... |
| 01.06.2022 | Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CARLSBAD, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity... |
| 27.04.2022 | Acutus Medical Announces Agreements to Fund Strategic Growth Priorities | CARLSBAD, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announc... |
| 27.04.2022 | Acutus Medical sells left-heart access portfolio to Medtronic in $50M deal | Acutus Medical (NSDQ:AFIB) today announced that it has entered a definitive agreement to sell its left-heart access portfolio to Medtronic (NYSE:MDT) for $50 million.
Medtronic will make an upfront cash payment to Princeton, N.J.–based Acut... |
| 30.03.2022 | Acutus Medical Reports Fourth Quarter and Full Year 2021 Financial Results | CARLSBAD, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reporte... |
| 19.01.2022 | Acutus Medical Announces Restructuring and Preliminary, Unaudited Fourth Quarter and Full Year 2021 Revenue | CARLSBAD, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announce... |
| 13.11.2021 | Acutus Medical : Reports Third Quarter 2021 Financial Results - Form 8-K | Acutus Medical Reports Third Quarter 2021 Financial Results
Carlsbad, Calif. - November 11, 2021 - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving th... |
| 12.11.2021 | Acutus Medical Reports Third Quarter 2021 Financial Results | CARLSBAD, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported... |
| 12.11.2021 | Acutus Medical Initiates CE Mark Study for Focal Pulsed Field Ablation Therapy to Treat Atrial Fibrillation | CARLSBAD, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the initiation ... |
| 11.11.2021 | Acutus Medical Reports Third Quarter 2021 Financial Results | CARLSBAD, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported... |
| 12.08.2021 | Acutus Medical : Reports Second Quarter 2021 Financial Results (Form 8-K) | Acutus Medical Reports Second Quarter 2021 Financial Results
Carlsbad, Calif. - August 12, 2021 - Acutus Medical, Inc. ('Acutus' or the 'Company') (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhyth... |
| 12.08.2021 | Acutus Medical : Reports Second Quarter 2021 Financial Results | CARLSBAD, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported... |
| 11.08.2021 | Acutus Medical : AcQMap 8, Acutus Medical's Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark | CARLSBAD, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced its innovative ... |
| 12.07.2021 | Acutus Medical, Inc. Announces Proposed Public Offering of Common Stock | CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today announced it has commenced an underwritten public offering of 5,500,000 shares of its common stock. All of the shares ... |
| 01.07.2019 | Acutus Medical Announces $170 Million Financing | Acutus Medical today announced a $170 million financing, including a $100 million Series D equity financing and a $70 million credit facility. The funding is intended to accelerate commercialization and facilitate global business developmen... |
| 24.06.2019 |
Acutus Medical Collects $170M
| Carlsbad-based Acutus Medical, a developer of cardiac imaging and mapping systems for real-time arrhythmia, has raised a big, $170 funding round, split between both equity and credit. According to the company, it raised $100M in a Series D ... |
| 21.06.2019 | Acutus Medical raises $170M to push it further into arrhythmia treatment
W h i t e p a p e r
Weighing the Costs: | On the heels of acquiring a catheter hardware developer and announcing a slew of new partnerships, Acutus Medical has now secured $170 million to move further into heart arrhythmia treatment delivery and monitoring.
Sponsored by Agilent Tec... |
| 21.06.2019 | Acutus Medical raises $170M to push it further into arrhythmia treatment | On the heels of acquiring a catheter hardware developer and announcing a slew of new partnerships, Acutus Medical has now secured $170 million to move further into heart arrhythmia treatment delivery and monitoring.
The financing includes a... |
| 20.06.2019 | Acutus Medical Announces $170 Million Financing | Acutus Medical today announced a $170 million financing, including a $100 million Series D equity financing and a $70 million credit facility. The funding is intended to accelerate commercialization and facilitate global business developmen... |
| 20.06.2019 | Acutus Medical Raises $170M Financing | Acutus Medical, a Carlsbad, Calif.-based dynamic arrhythmia care company, raised $170m financing.
This included a $100m Series D equity financing and a $70m credit facility.
The Series D equity financing included new investors 8VC, Opaleye ... |
| 20.06.2019 | Acutus Medical Announces $170 Million Financing | - |
| 18.06.2018 |
Acutus Medical Raises $22.8M
| Carlsbad-based Acutus Medical, a developer of a system which is being used to treat patients with complex atrial arrhythmias, has raised $22.8M in funding, as part of an ongoing $25M fundraising effort, according to a regulatory filing from... |
| 23.03.2016 | Acutus Medical Closes $75M Series C Financing | Acutus Medical, a Carlsbad, CA-based electrophysiology company focused on the development of medical technologies innovating the treatment of patients with complex cardiac arrhythmias, closed a $75m Series C financing.
The round included ne... |
| 22.03.2016 | Acutus Medical completes $75M Series C for its complex arrhythmia imaging system | The AcQMap allows an electro-physiologist to interpret if treatment is effective by using the technology to get a new map of the heart every hour following bursts of radio energy.
The all-equity financing round included new investors Deerfi... |
| 22.03.2016 |
Acutus Medical Raises $75M
| Carlsbad-based Acutus Medical, a developer ofmedical equipment for diagnosing and imaging cardiac arrhythmia, has raised $75M in a Series C funding, the company said this morning. The financing round came from Deerfield Management Company, ... |
| 30.09.2014 | Acutus Medical Completes $26.2M Financing | Acutus Medical, Inc., a San Diego, CA-based medical device company, completed an additional $26.2M financing.
The backers remained undisclosed.
The company intends to use the funds to expand product portfolio and continue to innovate and va... |
| 30.09.2014 | Acutus Medical Completes $26.2M Funding Round | Acutus Medical Inc., a San Diego-based medical device company developing tools for treating complex cardiac arrhythmias, announced it has completed a $26.2 million financing round to continue developing its imaging and mapping system.
The f... |
| 21.08.2013 | Acutus closes Series B round at $28M, with funding from GE and OrbiMed | San Diego medical device startup Acutus Medical closed its Series B funding round with $28 million raised from a handful of investors in support of the company’s minimally invasive heart mapping technology.
Acutus plans to use the funds to ... |
| 20.08.2013 |
Acutus Medical Closes Out Series B At $28M
| San Diego-based minimally invasive, cardiac catheter developer Acutus Medical reported Tuesday that it has closed out its Series B funding at $28M. According to the company, the round was led by OrbiMed Advisors and GE Ventures, and also in... |
| 20.08.2013 | Acutus Medical Completes $28M Series B Funding | Acutus Medical, Inc., a San Diego, CA-based medical device company developing a minimally invasive cardiac catheter for the treatment of irregular heart rhythms, completed a $28m Series B funding.
The round was led by new investor OrbiMed A... |
| 20.08.2013 | Acutus Medical Closes $28M in Series B |
SAN DIEGO, CA, Medical device company developing a minimally invasive cardiac catheter for the treatment of irregular heart rhythms, announced today that it has completed a $28 million Series B funding.
>> Click here for more fundi... |
| 20.08.2013 | GE invests in Afib market, helps minimally invasive imaging and mapping startup close $28M Series B round | Acutus CEO Randy Werneth said in a statement that the information this device gives should allow physicians to offer precise treatment and monitor therapy progress more efficiently.
(Earlier this week, St. Jude Medical acquired Endosense.)
... |
| 25.06.2013 |
Acutus Medical Gets $21M For 3D Medical Imaging
| San Diego-based Acutus Medical, a developer of medical devices used for 3D, cardiac chamber imaging, has raised $21M as part of a Series B financing, the firm announced this morning. The firm said the funding was led by OrbiMed, and also in... |
| 13.06.2013 | Acutus Medical charts $21M of a hoped-for $31M Series B round | Acutus Medical, fresh off a successful first-in-human trial of its heart-mapping technology, raised $21.6 million of a hoped-for $30.6 million Series B round, founder, president & CEO Randy Werneth told MassDevice.com today.
San Diego-b... |
| 08.08.2011 |
Acutus Medical Raises $1M
| San Diego-based Acutus Medical, a developer of medical devices for treating cardiac arrhythmia, said today that it has received $1M in a funding round. The round came form Index Ventures and un-named private investors. Acutus Medical said i... |
| 08.08.2011 | Acutus Medical Raises $1M in Initial Funding | Acutus Medical, a San Diego-based newly founded medical technology company, has raised $1m in start up funding.
Investors include Index Ventures and other private backers.
The company intends to use the funds to develop prototypes of its no... |
| 08.08.2011 | Acutus Medical Raises $1M |
Index Ventures, together with private investors, funded the medical technology company focused on developing a breakthrough device for real time mapping of Atrial Fibrillation.
>> Click here for more funding data on Acutus Medical
... |
| - | Acutus Medical completes $75M Series C for its complex arrhythmia imaging system | San Diego-based Acutus Medical, a device maker focused on diagnosing and treating irregular heartbeats, announced it has closed a $75 million Series C round of financing.
The company’s AcQMap technology provides a 3-D, high-resolution image... |
| - | GE invests in Afib market, helps minimally invasive imaging and mapping startup close $28M Series B round | The growing A-fib market continues to gain the attention of the major players this week: GE Ventures helped Acutus Medical to close a $28 million Series B round. The San Diego-based startup is working to develop a minimally invasive, real-t... |
